117 related articles for article (PubMed ID: 3247413)
1. Evaluation of circulating immune complexes in leprosy.
Ramos GS; Bottasso OA; Morini JC; Segal-Eiras A
Rev Argent Microbiol; 1988; 20(4):163-70. PubMed ID: 3247413
[TBL] [Abstract][Full Text] [Related]
2. Activation of complement by circulating immune complexes isolated from leprosy patients.
Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
[TBL] [Abstract][Full Text] [Related]
3. T lymphocyte subpopulations in leprosy patients and their relation with circulating immune complexes.
Bottasso OA; Morini JC; Ramos G; Segal-Eiras A
Allergol Immunopathol (Madr); 1990; 18(2):91-4. PubMed ID: 2142569
[TBL] [Abstract][Full Text] [Related]
4. A study on the methods for early serological diagnosis of leprosy and their potential use.
Wu Q; Li X; Yin Y; Shu H; Wei W; Liu Q; Ye G
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):302-5. PubMed ID: 10575411
[TBL] [Abstract][Full Text] [Related]
5. Identification of myelin basic proteins in circulating immune complexes associated with lepromatous leprosy.
Córsico B; Croce MV; Mukherjee R; Segal-Eiras A
Clin Immunol Immunopathol; 1994 Apr; 71(1):38-43. PubMed ID: 7511083
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes detected by C1q solid phase assay in leprosy.
Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
[TBL] [Abstract][Full Text] [Related]
7. Enzyme immunoassay of phagocytosis stimulating tetrapeptide "tuftsin" in normal and leprosy sera.
Kaur J; Khare S; Bhutani LK; Rao DN
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):576-81. PubMed ID: 1802940
[TBL] [Abstract][Full Text] [Related]
8. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
[TBL] [Abstract][Full Text] [Related]
9. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
[TBL] [Abstract][Full Text] [Related]
10. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
Mathew JM; Muthukkaruppan V
Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus infection in lepromatous and tuberculoid patients from Senegal.
Yvonnet B; Vincelot P; Millan J; Lesage G; Denis F; Languillon J; Mboup S; Coursaget P; Diop Mar I; Chiron JP
Acta Leprol; 1989; 7(1):63-6. PubMed ID: 2624077
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
[TBL] [Abstract][Full Text] [Related]
13. [Isolation and characterization of immune complexes associated with malignant tumors and leprosy].
Segal-Eiras A; Croce MV; Ramos GS; Córsico B
Medicina (B Aires); 1989; 49(2):125-30. PubMed ID: 2640480
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
Prasad CV; Kodliwadmath MV; Kodliwadmath GB
Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
[TBL] [Abstract][Full Text] [Related]
15. Production of host-protective (IFN-gamma), host-impairing (IL-10, IL-13) and inflammatory (TNF-alpha) cytokines by PBMC from leprosy patients stimulated with mycobacterial antigens.
Machado P; Abrams J; Santos S; Brennan P; Barral A; Barral-Netto M
Eur J Dermatol; 1998 Mar; 8(2):98-103. PubMed ID: 9649657
[TBL] [Abstract][Full Text] [Related]
16. The functional state of the complement system in leprosy.
Gomes GI; Nahn EP; Santos RK; Da Silva WD; Kipnis TL
Am J Trop Med Hyg; 2008 Apr; 78(4):605-10. PubMed ID: 18385356
[TBL] [Abstract][Full Text] [Related]
17. Significance of circulating immune complexes in pulmonary tuberculosis.
Samuel AM; Ashtekar MD; Ganatra RD
Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of two antigen nonspecific assays for circulating immune complexes using a model system.
Rodrick M; Rayner A; Steele G; Harte P; Finn D; Verhave M; Munroe A; Zamcheck N; Wilson R
J Clin Lab Immunol; 1982 Apr; 7(3):193-8. PubMed ID: 6178827
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
20. Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms.
Dornelles LN; Pereira-Ferrari L; Messias-Reason I
Clin Exp Immunol; 2006 Sep; 145(3):463-8. PubMed ID: 16907914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
